Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191840 · ClinicalTrials.gov registry record · Phase 2
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 509
- Enrollment target
NCT01191840 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 509 participants.
The verdict
NCT01191840, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 509 participants
- Enrollment target
Study Summary
The purpose of this study is to accurately determine the length of appropriate drug treatment for staphylococcal blood stream infection. The study seeks to address important information about the management of staphylococcal blood stream infections.
Interventions
- DRUG Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 509 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-03-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01191840
The ClinicalTrials.gov registry entry for NCT01191840 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 509 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vancomycin is the first listed.
NCT01191840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01191840 about?
NCT01191840 is a clinical study titled "Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection". The purpose of this study is to accurately determine the length of appropriate drug treatment for staphylococcal blood stream infection. The study seeks to address important information about the management of staphylococcal blood stream infections.
What is the current status of trial NCT01191840?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 509 participants. The study started on 2011-02. Estimated completion is 2017-03-04.
What interventions are being tested in trial NCT01191840?
The interventions under investigation include: Vancomycin (DRUG).
Who is sponsoring clinical trial NCT01191840?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.